| Republished review: Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient. | |
| | |
MedLine Citation:
|
PMID: 22048703 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Although statins significantly decrease the incidence of cardiovascular disease (CVD), residual CVD risk remains high. This may partly be due to uncorrected atherogenic dyslipidaemia. The driving force behind atherogenic dyslipidaemia is hypertriglyceridaemia, which results from hepatic oversecretion and/or hypocatabolism of triglyceride-rich lipoproteins, and is typical of type 2 diabetes and metabolic syndrome. Persistent atherogenic dyslipidaemia in patients treated with a statin according to low-density lipoprotein-cholesterol goals may be corrected with niacin, fibrates or n-3 fatty acids. Clinical trial evidence to inform best practice is limited, but new data support adding fenofibrate to a statin. A consistent feature of fibrate clinical trials is the specific benefit of these agents in dyslipidaemic patients and the improvement in diabetic retinopathy with fenofibrate. Ongoing clinical trials may provide good evidence for adding niacin to a statin. Low-dose n-3 fatty acids could be used routinely after a myocardial infarction, but the value of higher doses of n-3 fatty acids in reducing CVD risk remains to be demonstrated. |
| | |
Authors:
|
Gerald F Watts; Fredrik Karpe |
Related Documents
:
|
10361493 - Sol-gel thin-film immobilized soybean peroxidase biosensor for the amperometric determi... 11833643 - Preparative isolation and purification of salvianolic acid b from the chinese medicinal... 3391263 - New congeners of antihypertensive and antithrombotic 7-amino or 7-acetyl-aminosubstitut... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Postgraduate medical journal Volume: 87 ISSN: 1469-0756 ISO Abbreviation: Postgrad Med J Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2011-11-03 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0234135 Medline TA: Postgrad Med J Country: England |
Other Details:
|
Languages: eng Pagination: 776-82 Citation Subset: IM |
Affiliation:
|
School of Medicine and Pharmacology, University of Western Australia, GPO Box X2213, Perth, WA 6847, Western Australia. gerald.watts@uwa.edu.au. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effect of ginkgo biloba extract 50 on immunity and antioxidant enzyme activities in ischemia reperfu...
Next Document: Republished error management: Descriptions of verbal communication errors between staff. An analysis...